Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
Kiq Bio
|
| gptkbp:CEO |
gptkb:Charles_Wilson
|
| gptkbp:developedBy |
antibody-coupled T cell receptor (ACTR) therapies
|
| gptkbp:focusesOn |
immunotherapy
|
| gptkbp:founded |
2014
|
| gptkbp:founder |
gptkb:Charles_Wilson
|
| gptkbp:headquarters_location |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Unum Therapeutics Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:renamed |
gptkb:Cogent_Biosciences
|
| gptkbp:status |
defunct (as Unum Therapeutics, now Cogent Biosciences)
|
| gptkbp:stockSymbol |
gptkb:UMRX
|
| gptkbp:website |
https://www.unumrx.com/
|
| gptkbp:bfsParent |
gptkb:UMRX
|
| gptkbp:bfsLayer |
8
|